Liraglutide

WikiDoc Resources for Liraglutide
Articles
Most recent articles on Liraglutide Most cited articles on Liraglutide Review articles on Liraglutide Articles on Liraglutide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Liraglutide Images of Liraglutide Photos of Liraglutide Podcasts & MP3s on Liraglutide Videos on Liraglutide
Evidence Based Medicine
Cochrane Collaboration on Liraglutide Bandolier on Liraglutide TRIP on Liraglutide
Clinical Trials
Ongoing Trials on Liraglutide at Clinical Trials.gov Trial results on Liraglutide Clinical Trials on Liraglutide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Liraglutide NICE Guidance on Liraglutide NHS PRODIGY Guidance FDA on Liraglutide CDC on Liraglutide
Books
Books on Liraglutide
News
Liraglutide in the news Be alerted to news on Liraglutide News trends on Liraglutide
Commentary
Blogs on Liraglutide
Definitions
Definitions of Liraglutide
Patient Resources / Community
Patient resources on Liraglutide Discussion groups on Liraglutide Patient Handouts on Liraglutide Directions to Hospitals Treating Liraglutide Risk calculators and risk factors for Liraglutide
Healthcare Provider Resources
Symptoms of Liraglutide Causes & Risk Factors for Liraglutide Diagnostic studies for Liraglutide Treatment of Liraglutide
Continuing Medical Education (CME)
CME Programs on Liraglutide
International
Liraglutide en Espanol Liraglutide en Francais
Business
Liraglutide in the Marketplace Patents on Liraglutide
Experimental / Informatics
List of terms related to Liraglutide

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Liraglutide is a glucagon-like peptide-1 (GLP-1) analog that is being developed by Novo Nordisk for the treatment of type 2 diabetes.

Template:WikiDoc Sources